Determination of safe anti-tubercular therapy regimen following anti-tubercular drug induced hepatitis in patients with active tuberculosis

Journal Title: Journal of the Indian Medical Association - Year 2019, Vol 117, Issue 5

Abstract

To determine the safety of restarting isoniazid and rifampicin and etambutol or isoniazid pyrazinamid and ethambutol in patients who develop antitubercular drug induced hepatitis. In 22 tuberculosis patients, who developed antitubercular drug induced hepatitis were analysed, for reintroduction of antitubercular drugs, isoniazid, rifampicin and ethambutol in 11 patients (Group A) and isoniazid, pyrazinamide and ethambutol in another 11 patients (Group B), following clinical and biochemical (liver function test) normalization. During antitubercular drug induced period, hepatotoxic antitubercular drugs were withdrawn till clinical and biochemical normalization and non-hepatotoxic antitubercular drugs like streptomycin, ethambutol were given. Jaundice appeared at variable interval of 2-13 weeks after starting the antitubercular treatment and before enrolling into the study. All 22 patients with abnormal liver function on close followup, came back to normal within 2 weeks of stoppage of antitubercular drug. On rechallange, 4 out of 11 patients receiving isoniazid and rifampicin developed hepatitis within 2-4 weeks of restart of therapy and 1 out of 11 developed (receiving isoniazid and pyrazinamide) in 4th week. Though the study sample size was small, the combination of isoniazid and pyrazinamide was apparently safer compared to isoniazid and rifampicin combination though it was statistically insignificant (p<0.155).

Authors and Affiliations

Atanu Ghosh

Keywords

Related Articles

Analysis of factors influencing lack of response in patients under Revised National Tuberculosis Control Programme (RNTCP) protocol

Tuberculosis (TB) is one of the most prevailing, contagious, chronic and a morbid infection. Our country has a high burden of TB. According to 2015 WHO statistics, India alone accounts to 23% of the total global incidenc...

Nailing fracture shaft both bone forearm in adults using rush rod : a retrospective study

Plating fracture both bone forearm (FBBFA) is gold standard but closed nailing using solid nails, age old practice is still continuing in this region mainly for economic patients. So how much effective is this closed nai...

Safety and performance of a levonorgestrel-releasing intrauterine contraceptive device : one-year outcomes of Fiona-1 clinical registry

The objective of the Fiona-1 registry (CTRI/2016/03/006781) is to assess the safety and performance of levonorgestrel-releasing intrauterine device (LNG-IUD), Fiona. This was a prospective, open-label, single-arm study c...

Evaluation of awareness and practice of pharmacovigilance among medical practitioners

The recent launch of National Pharmacovigilance program which is still in infancy. In India, problem is under-reporting of ADRs. This study was aimed at investigating the knowledge, attitude and awareness about ADR repor...

Search for Light

Let me start quoting the GEETA’S eternal massage ‘what happened in the past was right and good, what is happening today is right and good and what will happen tomorrow will be right and good; we are to serve our duties f...

Download PDF file
  • EP ID EP626272
  • DOI -
  • Views 118
  • Downloads 0

How To Cite

Atanu Ghosh (2019). Determination of safe anti-tubercular therapy regimen following anti-tubercular drug induced hepatitis in patients with active tuberculosis. Journal of the Indian Medical Association, 117(5), 13-19. https://europub.co.uk/articles/-A-626272